MDT-AP-2110
Med · Medulloblastoma
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- Med
- cancer_type_detailed
- —
- subtype
- Medulloblastoma
- cancer_type
- Med
- subtype
- Medulloblastoma
- overall_survival_months
- 18
- os_event
- true
- age_years
- 2
- sex
- M
- fusion
- other ZFTA
- new_clusters
- C1
- umap1_2d
- 4.192869705
- umap2_2d
- -0.721550401
- umap1_3d
- -0.051707545
- umap2_3d
- -4.031842703
- umap3_3d
- -0.630195752
- dataset
- Med-Taylor
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | MDT-AP-2497 | Med | Medulloblastoma | 0.916 |
| 2 | MDT-AP-2180 | Med | Medulloblastoma | 0.898 |
| 3 | MNG925 | — | — | 0.887 |
| 4 | TCGA-98-A538-01A-11R-A262-07 | — | cohortSQ1 | 0.878 |
| 5 | MDT-AP-3297 | Med | Medulloblastoma | 0.870 |
| 6 | TCGA-94-7557-01A-11R-2125-07 | — | cohortMD1 | 0.869 |
| 7 | 1764b9ab-4f37-47c5-8225-40c574433f40 | — | — | 0.861 |
| 8 | E0DE33EA-C3DF-478E-9C4D-86E3C7B3A1D9 | — | — | 0.861 |
| 9 | MNG753 | — | — | 0.857 |
| 10 | MDT-AP-3285 | Med | Medulloblastoma | 0.856 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 26 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| E2F_TARGETS | 0.650 | Inavolisib | — uncovered |
| G2M_CHECKPOINT | 0.610 | Inavolisib | — uncovered |
| MYC_TARGETS_V1 | 0.570 | Inavolisib | — uncovered |
| MYC_TARGETS_V2 | 0.540 | Idelalisib | — uncovered |
| DNA_REPAIR | 0.460 | Idelalisib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.450 | Remibrutinib | — uncovered |
| MTORC1_SIGNALING | 0.410 | Inavolisib | — uncovered |
| MITOTIC_SPINDLE | 0.400 | Inavolisib | — uncovered |
| TGF_BETA_SIGNALING | 0.390 | Inavolisib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.330 | Idelalisib | — uncovered |
| FATTY_ACID_METABOLISM | 0.280 | Inavolisib | — uncovered |
| PI3K_AKT_MTOR_SIGNALING | 0.270 | Inavolisib | — uncovered |
| PEROXISOME | 0.240 | Idelalisib | — uncovered |
| ADIPOGENESIS | 0.230 | Inavolisib | — uncovered |
| ANDROGEN_RESPONSE | 0.230 | Inavolisib | — uncovered |
| UV_RESPONSE_UP | 0.230 | Idelalisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.190 | Inavolisib | — uncovered |
| CHOLESTEROL_HOMEOSTASIS | 0.130 | Remibrutinib | — uncovered |
| GLYCOLYSIS | 0.090 | Inavolisib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.080 | Inavolisib | — uncovered |